Pronovost Peter J, Demski Renee, Callender Tiffany, Winner Laura, Miller Marlene R, Austin J Matthew, Berenholtz Sean M
Armstrong Institute for Patient Safety and Quality, John Hopkins Medicine, Baltimore, MD, USA.
Armstrong Institute for Patient Safety and Quality, Johns Hopkins Health System, Baltimore, MD, USA.
Jt Comm J Qual Patient Saf. 2013 Dec;39(12):531-44. doi: 10.1016/s1553-7250(13)39069-2.
Patients continue to suffer preventable harm from the omission of evidence-based therapies. To remedy this, The Joint Commission developed core measures for therapies with strong evidence and, through the Top Performer on Key Quality Measures program, recognize hospitals that deliver those therapies to 95% of patients. The Johns Hopkins Medicine board of trustees committed to high reliability and to providing > or = 96% of patients with the recommended therapies.
The Armstrong Institute for Patient Safety and Quality coordinated the core measures initiative, which targeted nine process measures for the 96% performance goal: eight Joint Commission accountability measures and one Delmarva Foundation core measure. A conceptual model for this initiative included communicating goals, building capacity with Lean Sigma methods, transparently reporting performance and establishing an accountability plan, and developing a sustainability plan. Clinicians and quality improvement staff formed one team for each targeted process measure, and Armstrong Institute staff supported the teams work. The primary performance measure was the percentage of patients who received the recommended process of care, as defined by the specifications for each of The Joint Commission's accountability measures.
The > or = 96% performance goal was achieved for 82% of the measures in 2011 and 95% of the measures in 2012.
With support from leadership and a conceptual model to communicate goals, use robust improvement methods, and ensure accountability, The Johns Hopkins Hospital achieved high reliability for The Joint Commission accountability measures.
患者仍因未采用循证疗法而遭受可预防的伤害。为纠正这一情况,联合委员会制定了针对有充分证据的疗法的核心指标,并通过“关键质量指标卓越表现者”计划,表彰那些为95%的患者提供这些疗法的医院。约翰·霍普金斯医学院董事会致力于实现高可靠性,并为96%或更多的患者提供推荐疗法。
阿姆斯特朗患者安全与质量研究所协调了核心指标倡议,该倡议针对96%的绩效目标制定了九项流程指标:八项联合委员会问责指标和一项德尔马瓦基金会核心指标。该倡议的概念模型包括传达目标、采用精益西格玛方法建设能力、透明报告绩效并制定问责计划,以及制定可持续性计划。临床医生和质量改进人员针对每项目标流程指标组成一个团队,阿姆斯特朗研究所的工作人员支持这些团队的工作。主要绩效指标是接受联合委员会每项问责指标所规定的推荐护理流程的患者百分比。
2011年82%的指标以及2012年95%的指标实现了96%或更高的绩效目标。
在领导层的支持以及一个用于传达目标、运用强大改进方法并确保问责的概念模型的支持下,约翰·霍普金斯医院在联合委员会问责指标方面实现了高可靠性。